IMDRF’s New Regulatory Landscape for Personalized Medical Devices

by | Jul 20, 2020 | FDA, Medical Devices, Regulatory

The International Medical Device Regulators Forum (IMDRF) has recently issued a final guidance document to outline its expectations around the regulatory landscape for personalized medical devices. This recent guidance document builds on the previous IMDRF document, ‘Definitions for Personalized Medical Devices’.1

According to the guidance document, custom made medical devices that are intended to treat/diagnose special cases where commercially available products/therapies are inadequate for meeting the needs of particular individuals must comply with the following requirements:2

  • Determine the classification of the device assuming it is not a custom-made product and consider applying the equivalent regulatory requirements of the jurisdiction it is sold in.
  • Conduct Risk analysis
  • Appropriate physical testing
  • Manufacturing and record-keeping under a Quality Management System
  • For high-risk custom-made devices, IMDRF recommends a third-party oversight such as that of an auditing organization for their QMS
  • Registration and notification as per applicable jurisdictional regulatory authorities
  • Follow a post-market surveillance, corrective, and adverse event reporting program

For patient-matched medical devices where the devices are designed and produced for an individual within validated parameters of a specified design, the manufacturer must demonstrate safety by identifying the maximum performance limits and limiting configurations related to manufacturing variables.21

In addition to all of this, manufacturers of personalized medical devices must keep records of the documented requests and specific design characteristics from the health care professionals. For implantable medical devices, IMDRF recommends a period of at least 15 years for housing such records and for all other devices at least 5 years.2

Need help building a QMS? Call us today at 248-987-4497 or email us at

1BSI (July 2020) New guidance on regulatory pathways for personalized medical devices retrieved on 07/13/2020 from

2IMDRF (March 2020) Personalized Medical Devices- Regulatory Pathways retrieved on 07/13/2020 from


Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This